Genomic testing involves analyzing the DNA of cancer cells to identify genetic mutations that are driving the disease. Techniques like Next-Generation Sequencing (NGS) enable comprehensive profiling of tumors, revealing specific genetic alterations that can be targeted with personalized treatments. This approach not only improves diagnostic accuracy but also guides the selection of the most effective therapies.
